Clinical Trials Browser

Phase 1/2 × serabelisib × 1 year × Clear all

NCT07558733 2026-04-30

Sapanisertib and Serabelisib (PIKTOR) in Various Combinations in Patients With HR+/HER2- Advanced/Metastatic Breast Cancer

Phase 1/2 Recruiting

Breast Neoplasms, Hereditary Sensory and Autonomic Neuropathies